{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:00:25Z","timestamp":1790002825887,"version":"4.0.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Antibiotics are major drivers of microbiome disruption in oncology, but they do not fully explain the ecological changes observed during cytotoxic treatment. The central question of this Mini Review is when chemotherapy-associated microbiome change should be interpreted as transient compositional variation and when it constitutes a loss of ecosystem function with potential clinical consequences. We use collateral microbiome injury as a conceptual framework, rather than a formally established clinical diagnosis, to describe treatment-associated loss of microbial load, function, spatial organization, colonization resistance, or recovery capacity that is not required for antitumor activity. Three questions organize the review: which changes are directly attributable to a defined chemotherapeutic agent; which arise from the broader oncology exposome, including mucosal injury, antibiotics, nutritional disturbance, hospitalization, and supportive medications; and which ecological mechanisms are inferred from non-chemotherapy models. The evidence is therefore classified as direct chemotherapy evidence, oncology-exposome evidence, or general ecological evidence. Agent-specific studies support microbial transformation of irinotecan and fluoropyrimidines, whereas longitudinal leukemia studies more often capture composite treatment episodes. Across these settings, depletion of obligate anaerobe functions, altered nutrient and redox conditions, pathobiont domination, oral-to-gut niche coalescence, and impaired recovery may weaken colonization resistance. However, the strongest persistent-disruption and infection data arise from intensive hematologic treatment and should not be generalized uncritically to conventional solid-tumor chemotherapy. We propose operational criteria, multidimensional recovery metrics, and evidence-stratified translational priorities for moving from descriptive dysbiosis toward testable, microbiome-sparing supportive care.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1955949","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:04:36Z","timestamp":1789999476000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond antibiotics: collateral damage to the gut microbiome during cancer therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Tong","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Thyroid and Head and Neck Surgery II, Jilin Provincial Cancer Hospital","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshi","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Head and Neck Surgery I, Jilin Provincial Cancer Hospital","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Ultrasound Department, Jilin Provincial Cancer Hospital","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Integrated Traditional Chinese and Western Medicine, Jilin Provincial Cancer Hospital","place":["Changchun, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.chom.2024.07.026","article-title":"Metabolite-based inter-kingdom communication controls intestinal tissue recovery following chemotherapeutic injury.","volume":"32","author":"Anderson","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2570502","DOI":"10.1080\/29933935.2025.2570502","article-title":"Gut microbiome features and resistome elements associated with colonization and infection with antibiotic-resistance threats.","volume":"2","author":"Batool","year":"2025","journal-title":"Gut Microbes Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1073\/pnas.1918095117","article-title":"Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy.","volume":"117","author":"Bhatt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41698-025-01034-0","article-title":"The role of the gut microbiota in chemotherapy response, efficacy and toxicity: A systematic review.","volume":"9","author":"B\u00f6hm","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","article-title":"Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.","volume":"517","author":"Buffie","year":"2015","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1126\/science.aam9949","article-title":"Microbiota-activated PPAR-\u03b3 signaling inhibits dysbiotic Enterobacteriaceae expansion.","volume":"357","author":"Byndloss","year":"2017","journal-title":"Science"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.1224203","article-title":"The application of ecological theory toward an understanding of the human microbiome.","volume":"336","author":"Costello","year":"2012","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.chom.2024.05.009","article-title":"Response, resistance, and recovery of gut bacteria to human-targeted drug exposure.","volume":"32","author":"de la Cuesta-Zuluaga","year":"2024","journal-title":"Cell Host Microbe"},{"key":"B9","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1073\/pnas.1000087107","article-title":"Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.","volume":"108","author":"Dethlefsen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s41586-021-04177-9","article-title":"Combinatorial, additive and dose-dependent drug-microbiome associations.","volume":"600","author":"Forslund","year":"2021","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/cncr.30039","article-title":"The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.","volume":"122","author":"Galloway-Pe\u00f1a","year":"2016","journal-title":"Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13073-017-0409-1","article-title":"Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.","volume":"9","author":"Galloway-Pe\u00f1a","year":"2017","journal-title":"Genome Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3389\/fmicb.2017.02224","article-title":"Microbiome datasets are compositional: And this is not optional.","volume":"8","author":"Gloor","year":"2017","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41586-025-09217-2","article-title":"Non-antibiotics disrupt colonization resistance against enteropathogens.","volume":"644","author":"Grie\u00dfhammer","year":"2025","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciy153","article-title":"Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia.","volume":"67","author":"Hakim","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2319511","article-title":"Chemotherapy-induced microbiota exacerbates the toxicity of chemotherapy through the suppression of interleukin-10 from macrophages.","volume":"16","author":"He","year":"2024","journal-title":"Gut Microbes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e00930-25","DOI":"10.1128\/mbio.00930-25","article-title":"Microbial vitamin biosynthesis links gut microbiota dynamics to chemotherapy toxicity.","volume":"16","author":"Hillege","year":"2025","journal-title":"mBio"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2024-334699","article-title":"Bacteroides intestinalis mediates the sensitivity to irinotecan toxicity via tryptophan catabolites.","volume":"75","author":"Hou","year":"2026","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1800897","DOI":"10.1080\/19490976.2020.1800897","article-title":"Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: The role of mucosal strengthening.","volume":"12","author":"Hueso","year":"2020","journal-title":"Gut Microbes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.chom.2018.07.002","article-title":"A gut commensal-produced metabolite mediates colonization resistance to Salmonella infection.","volume":"24","author":"Jacobson","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2020.05.001","article-title":"Personalized mapping of drug metabolism by the human gut microbiome.","volume":"181","author":"Javdan","year":"2020","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40164-025-00661-4","article-title":"Unravelling neutropenic enterocolitis: Insights from gut microbiota, and intestinal barrier analyses.","volume":"14","author":"Kapandji","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41586-021-03891-8","article-title":"Bioaccumulation of therapeutic drugs by human gut bacteria.","volume":"597","author":"Kl\u00fcnemann","year":"2021","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41586-025-09273-8","article-title":"Identification of medication-microbiome interactions that affect gut infection.","volume":"644","author":"Kumar","year":"2025","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"111625","DOI":"10.1016\/j.celrep.2022.111625","article-title":"The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota.","volume":"41","author":"LaCourse","year":"2022","journal-title":"Cell. Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e00816-23","DOI":"10.1128\/msphere.00816-23","article-title":"Anaerostipes hadrus, a butyrate-producing bacterium capable of metabolizing 5-fluorouracil.","volume":"9","author":"Liu","year":"2024","journal-title":"mSphere"},{"key":"B29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota.","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria.","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1182\/bloodadvances.2024015571","article-title":"Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: The phase 1b CIMON trial.","volume":"9","author":"Malard","year":"2025","journal-title":"Blood Adv."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","article-title":"Reporting guidelines for human microbiome research: The STORMS checklist.","volume":"27","author":"Mirzayi","year":"2021","journal-title":"Nat. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","article-title":"Chemotherapy-driven dysbiosis in the intestinal microbiome.","volume":"42","author":"Montassier","year":"2015","journal-title":"Aliment Pharmacol. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.chom.2020.12.008","article-title":"Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation.","volume":"29","author":"Nayak","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/infdis\/jiad033","article-title":"Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients.","volume":"228","author":"N\u00f8rgaard","year":"2023","journal-title":"J. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.clnu.2023.09.021","article-title":"Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss.","volume":"42","author":"P\u00f6tgens","year":"2023","journal-title":"Clin. Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1182\/bloodadvances.2021006783","article-title":"Lasting shift in the gut microbiota in patients with acute myeloid leukemia.","volume":"6","author":"Rashidi","year":"2022","journal-title":"Blood Adv."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.1200\/JCO.22.02366","article-title":"Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and acute myeloid leukemia.","volume":"41","author":"Rashidi","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/cncr.32641","article-title":"Gut dysbiosis during antileukemia chemotherapy versus allogeneic hematopoietic cell transplantation.","volume":"126","author":"Rashidi","year":"","journal-title":"Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41375-019-0547-0","article-title":"Specific gut microbiota changes heralding bloodstream infection and neutropenic fever during intensive chemotherapy.","volume":"34","author":"Rashidi","year":"","journal-title":"Leukemia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1038\/s41598-019-42652-6","article-title":"Dysbiosis patterns during re-induction\/salvage versus induction chemotherapy for acute leukemia.","volume":"9","author":"Rashidi","year":"2019","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41522-025-00725-7","article-title":"Distal gut colonization by oral bacteria during intensive chemotherapy: Direct evidence from strain-level analysis of paired samples.","volume":"11","author":"Raychaudhuri","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41564-023-01581-x","article-title":"High-throughput transcriptomics of 409 bacteria-drug pairs reveals drivers of gut microbiota perturbation.","volume":"9","author":"Ricaurte","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1084\/jem.20181639","article-title":"Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification.","volume":"216","author":"Sorbara","year":"2019","journal-title":"J. Exp. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s41591-018-0202-8","article-title":"Precision identification of diverse bloodstream pathogens in the gut microbiome.","volume":"24","author":"Tamburini","year":"2018","journal-title":"Nat. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation.","volume":"55","author":"Taur","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e00045-15","DOI":"10.1128\/mSphere.00045-15","article-title":"Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth.","volume":"1","author":"Theriot","year":"2016","journal-title":"mSphere"},{"key":"B48","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1172\/JCI43918","article-title":"Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans.","volume":"120","author":"Ubeda","year":"2010","journal-title":"J. Clin. Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature24460","article-title":"Quantitative microbiome profiling links gut community variation to microbial load.","volume":"551","author":"Vandeputte","year":"2017","journal-title":"Nature"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e4017","DOI":"10.7717\/peerj.4017","article-title":"5-Fluorouracil and irinotecan (SN-38) have limited impact on colon microbial functionality and composition in vitro.","volume":"5","author":"Vanlancker","year":"2017","journal-title":"PeerJ"},{"key":"B51","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","article-title":"The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide.","volume":"342","author":"Viaud","year":"2013","journal-title":"Science"},{"key":"B52","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","article-title":"Host variables confound gut microbiota studies of human disease.","volume":"587","author":"Vujkovic-Cvijin","year":"2020","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme.","volume":"330","author":"Wallace","year":"2010","journal-title":"Science"},{"key":"B54","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.1232467","article-title":"Host-derived nitrate boosts growth of Escherichia coli in the inflamed gut.","volume":"339","author":"Winter","year":"2013","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41467-026-68741-5","article-title":"Kynurenine mediates chemotherapy-induced intestinal toxicity through modulation of gut microbiota.","volume":"17","author":"Xie","year":"2026","journal-title":"Nat. Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12866-025-04704-y","article-title":"Longitudinal analysis of postoperative chemotherapy on oral-gut microbiota in patients with advanced gastric cancer.","volume":"26","author":"Xu","year":"2026","journal-title":"BMC Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"ycag127","DOI":"10.1093\/ismeco\/ycag127","article-title":"Bifidobacterium animalis subsp. lactis V9 improves quality of life in advanced gastrointestinal cancer through gut microbiota-metabolite modulation.","volume":"6","author":"Yang","year":"2026","journal-title":"ISME Commun."},{"key":"B58","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes.","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1955949\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:04:37Z","timestamp":1789999477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1955949\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":58,"alternative-id":["10.3389\/fmicb.2026.1955949"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1955949","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1955949"}}